| Pharmaceutical active ingredients: |
| Natalizumab |
| Available forms, composition and doses of Anti-VLA4: |
| N / A |
| Anti-VLA4 medical category: |
| Human:Humanized monoclonal antibodiesMultiple sclerosis and Crohn's disease treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L04AA23 - Natalizumab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Antitanil | Vitamin D4 | Unidentified Pharmaceutical Company |
| Antitrombosin | Dicumarol | Unidentified Pharmaceutical Company |
| Antituberkulosum | Isoniazid | Unidentified Pharmaceutical Company |
| Antivegf | Bevacizumab | Unidentified Pharmaceutical Company |
| Antivitium | Disulfiram | Unidentified Pharmaceutical Company |
| Antodine | Famotidine | Unidentified Pharmaceutical Company |
| Antomin | Diphenhydramine | Unidentified Pharmaceutical Company |
| Antophysin | Gonadotropin | Unidentified Pharmaceutical Company |
| Antora | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Antorfin | Nalorphine | Unidentified Pharmaceutical Company |